Literature DB >> 3028205

Properties of radiolabeled type I, II, and III collagens related to their use as substrates in collagenase assays.

K A Mookhtiar, S K Mallya, H E Van Wart.   

Abstract

Calf skin and rat tendon type I, bovine cartilage type II, and human amnion type III collagens have been radiolabeled by reaction with [3H]acetic anhydride, [3H]formaldehyde, and succinimidyl 2,3-[3H]propionate. All three reactions produce collagens with high specific activities that are suitable for use as substrates in collagenase assays. The identity of the radiolabel and the labeling indices do not alter the molecular weights or thermal stabilities of the collagens or the solubilities of the collagens or gelatins in dioxane-water mixtures at 4 degrees C. However, in contrast to native or sparsely labeled collagens, those with 40 or more lysine + hydroxylysine residues labeled per molecule do not undergo fibrillogenesis in the presence of 0.2-0.4 M NaCl in the 4-35 degree C temperature range. Thus, the modification reactions not only serve to introduce the radiolabel, but also to keep the collagens soluble over a wide range of temperatures and concentrations. The TCA, TCB fragments produced on partial reaction of each collagen type with tissue collagenases can be selectively denatured by a 10-minute incubation under specific conditions and the intact collagens selectively precipitated by addition of 50% v/v dioxane. This serves as the basis for soluble collagenase assays. The effect of labeling index on the properties of the collagens has been investigated and the results establish the range of conditions over which these collagens can be used as substrates for soluble versus fibrillar collagenase assays.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028205     DOI: 10.1016/0003-2697(86)90557-9

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  8 in total

1.  Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability.

Authors:  M F French; A Bhown; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

2.  Kinetics of hydrolysis of type I, II, and III collagens by the class I and II Clostridium histolyticum collagenases.

Authors:  S K Mallya; K A Mookhtiar; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

3.  General protease and collagenase (IV) activity in C6 astrocytoma cells, C6 spheroids and implanted C6 spheroids.

Authors:  I S Vaithilingam; E C Stroude; W McDonald; R F Del Maestro
Journal:  J Neurooncol       Date:  1991-06       Impact factor: 4.130

4.  Identification, purification and partial characterization of tissue inhibitor of matrix metalloproteinase-2 in bovine pulmonary artery smooth muscle.

Authors:  Malay Mandal; Amritlal Mandal; Sudip Das; Tapati Chakraborti; Sajal Chakraborti
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

5.  Comparison of techniques for measurement of gelatinases/type IV collagenases: enzyme-linked immunoassays versus substrate degradation assays.

Authors:  S Zucker; P Mancuso; B DiMassimo; R M Lysik; C Conner; C L Wu
Journal:  Clin Exp Metastasis       Date:  1994-01       Impact factor: 5.150

6.  Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase.

Authors:  K C Fang; W W Raymond; S C Lazarus; G H Caughey
Journal:  J Clin Invest       Date:  1996-04-01       Impact factor: 14.808

7.  Degraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talin.

Authors:  N O Carragher; B Levkau; R Ross; E W Raines
Journal:  J Cell Biol       Date:  1999-11-01       Impact factor: 10.539

8.  Biochemical characterisation of a collagenase from Bacillus cereus strain Q1.

Authors:  Isabel J Hoppe; Hans Brandstetter; Esther Schönauer
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.